View Cart  

OGD Director Greg Geba Resigns, Citing Differences in Vision

A A
Office of Generic Drugs (OGD) Director Greg Geba is resigning, effective Friday — less than a year after taking charge.

To View This Article:

Login

Subscribe To Drug Industry Daily